[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT05978128":3,"trial-entities:NCT05978128":104,"trial-summary:NCT05978128":107},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":21,"study_type":22,"primary_purpose":23,"phases":24,"enrollment_info":26,"interventions":29,"primary_outcomes":50,"secondary_outcomes":55,"sex":59,"minimum_age":60,"maximum_age":61,"healthy_volunteers":62,"eligibility_criteria":63,"std_ages":77,"locations":80,"central_contacts":98,"overall_officials":99,"references":102,"see_also_links":103},"NCT05978128","22-000947","Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants","Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates","RECRUITING","2029-09-30","2025-11","2025-11-10","2023-07-28","Jonsson Comprehensive Cancer Center","OTHER",false,"This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.","PRIMARY OBJECTIVES:\n\nI. Determine the number of patients undergoing breast screening who are eligible to participate in lung screening.\n\nII. Determine whether patients currently participating in cancer screening (breast OR lung) are successful as \"cancer screening advocates.\" III. Determine whether laypersons who are aware of screening (including those who accompany friends and family members to their screening appointments) are successful as \"cancer screening advocates.\" IV. Identify knowledge base and psychological barriers to screening through surveys of potential screening participants.\n\nOUTLINE:\n\nParticipants access an electronic patient portal with educational materials at baseline, 1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients also receive materials to share with their friends\u002Ffamily on benefits of breast and lung cancer screening on study.\n\nAfter completion of study intervention, participants are followed up yearly for up to 3 years.",[19,20],"Breast Carcinoma","Lung Carcinoma",[],"INTERVENTIONAL","SCREENING",[25],"NA",{"count":27,"type":28},800,"ESTIMATED",[30,36,40,46],{"type":31,"name":32,"description":33,"armGroupLabels":34},"BEHAVIORAL","Health Education","Access electronic patient portal with educational material",[35],"Screening (electronic patient portal, patient navigation)",{"type":14,"name":37,"description":38,"armGroupLabels":39},"Health Promotion and Education","Receive materials on breast\u002Flung cancer screening",[35],{"type":31,"name":41,"description":42,"armGroupLabels":43,"otherNames":44},"Patient Navigation","Interact with a patient navigator",[35],[45],"Patient Navigator Program",{"type":14,"name":47,"description":48,"armGroupLabels":49},"Survey Administration","Ancillary studies",[35],[51],{"measure":52,"description":53,"timeFrame":54},"Increased rates of lung and breast cancer screening adherence","By following up with patients over the defined study period and assessing whether they obtained an incidence screen completed at one-year +\u002F- 3 months from the recommended time. Will also measure the rates of survey completion by consented participants, the number of clicks and time spent reviewing educational materials, and the number of new participants who contacted the program through a referral by another participant.","Up to 3 years",[56],{"measure":57,"description":58,"timeFrame":54},"Success of \"sphere of influence\" model","Considered successful if increased lung cancer screening referrals are a direct result of women receiving screening mammograms inviting and educating friends and family about lung cancer screening.","ALL","40 Years","80 Years",true,{"inclusion":64,"exclusion":71,"raw_text":76},[65,66,67,68,69,70],"Age:","Breast screening \\> 40","Lung screening 50-80","Male (M) or Female (F)","Current, former, or never smokers","Close family or friend with smoking history (in or out of state)",[65,72,73,74,75],"Breast screening \\\u003C 40","Lung screening \\\u003C 50 or \\> 80","Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded","Persons with an active cancer","Inclusion Criteria:\n\n* Age:\n\n  * Breast screening \\> 40\n  * Lung screening 50-80\n* Male (M) or Female (F)\n* Current, former, or never smokers\n* Close family or friend with smoking history (in or out of state)\n\nExclusion Criteria:\n\n* Age:\n\n  * Breast screening \\\u003C 40\n  * Lung screening \\\u003C 50 or \\> 80\n* Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded\n* Persons with an active cancer",[78,79],"ADULT","OLDER_ADULT",[81],{"facility":82,"status":8,"city":83,"state":84,"zip":85,"country":86,"contacts":87,"geoPoint":95},"UCLA \u002F Jonsson Comprehensive Cancer Center","Los Angeles","California","90095","United States",[88,93],{"name":89,"role":90,"phone":91,"email":92},"Ashley E. Prosper","CONTACT","310-825-0958","APROSPER@MEDNET.UCLA.EDU",{"name":89,"role":94},"PRINCIPAL_INVESTIGATOR",{"lat":96,"lon":97},34.05223,-118.24368,[],[100],{"name":101,"affiliation":82,"role":94},"Ashley E Prosper",[],[],{"nct_id":4,"conditions":105,"biomarkers":106},[19,20],[],{"nct_id":4,"found":62,"summary":108,"prompt_version":118},{"design":109,"status":110,"heading":111,"summary":112,"follow_up":113,"word_count":114,"commitments":115,"compensation":116,"drugs_mentioned":117},"This interventional study plans to enroll 800 participants. It is not specified if the study is randomized or blinded.","completed","Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates","This study is looking at ways to increase lung cancer screening rates, especially since breast cancer screening is more commonly used. Researchers want to see if using advocates and supporters, including people who already get cancer screenings or those who accompany friends\u002Ffamily to appointments, can help encourage more eligible people to get lung cancer screenings. You might be able to join if you are between 40 and 80 years old, regardless of gender, and have a history of smoking or a close family member with a smoking history. The study will measure if these efforts lead to more people getting screened for lung and breast cancer over three years. The goal is to understand and overcome reasons why lung cancer screening isn't used as much, like fear or lack of awareness.","Participants are followed yearly for up to 3 years after the study intervention is completed.",131,"You would access an electronic patient portal with educational materials at the start and at 1- and 2-year follow-ups. You would also interact with a patient navigator and receive materials to share with friends\u002Ffamily.","Not stated in the trial record.",[],"v2"]